No products in the cart.

Loyalty reward — every 5 orders, get NZ$50.00 off automatically at checkout.

PCT and Ancillary Compounds in Research — SERMs, AIs, and Support Agents

Clomid, tamoxifen, aromatase inhibitors, cabergoline, and proviron as research references — how NZ labs source ancillaries from Kiwi Biolab.

PCT and Ancillary Compounds in Research

Endocrine research rarely stops at the primary androgen or SARM. Programmes that manipulate the hypothalamic–pituitary–gonadal (HPG) axis often require selective oestrogen receptor modulators (SERMs), aromatase inhibitors (AIs), and dopamine agonists as controlled comparator or rescue arms.

Kiwi Biolab groups these with other oral compounds. This article describes their research roles — not clinical post-cycle therapy advice. All products are for laboratory use only.


SERMs: Oestrogen Receptor Modulation

SERMs block or activate oestrogen receptors tissue-selectively — useful when studying feedback on LH/FSH, breast tissue models, or bone density under oestrogen manipulation.

Compound Listing Research relevance
Clomiphene Clomid 50mg HPG axis recovery signalling in animal models
Tamoxifen Tamoxifen 20mg ER antagonism in mammary and bone endpoints

Pair SERM arms with testosterone oils or SARM protocols only when ethics documents justify combination exposure.


Aromatase Inhibitors: Oestrogen Synthesis Blockade

Aromatase converts androgens to oestrogens. Inhibitors are used to study aromatisation, bone loss, and lipid changes when oestrogen is suppressed.

Compound Listing Notes
Anastrozole Arimidex 1mg Non-steroidal AI; potent suppression
Exemestane Aromasin 25mg Steroidal, irreversible aromatase inhibitor
Letrozole Femara 2.5mg High potency; low-dose arms common

Document baseline oestradiol assays in protocols that include AIs alongside nandrolone or testosterone references.


Proviron and Androgenic Ancillaries

Mesterolone (Proviron) is a DHT-like oral androgen used in fertility and SHBG-binding research:

It complements rather than replaces SERMs in many published animal designs — check primary literature for your species.


Cabergoline: Dopamine Agonist Reference

Cabergoline is a long-acting dopamine D₂ agonist used in prolactin modulation studies (e.g. pituitary hyperprolactinaemia models):

Strength Listing
0.5mg Cabergoline 0.5mg
1mg Cabergoline 1mg

Prolactin elevation sometimes appears in androgen or nor-androgen protocols; cabergoline arms help isolate dopaminergic rescue effects.


Building a Complete NZ Research Order

A typical endocrine programme might source from one domestic cart:

  1. Primary agent — e.g. Sustanon 250 or RAD-140
  2. Aromatase control — e.g. Anastrozole 1mg
  3. SERM comparator — e.g. Tamoxifen 20mg
  4. Peptide adjunct — e.g. BPC-157 for tissue-injury substudies

Kiwi Biolab advantages for New Zealand buyers:

  • NZ-owned, NZD pricing, discreet NZ-wide shipping
  • Janoshik-tested peptide lines plus labelled orals/oils
  • Local support when matching SKUs to ethics paperwork

Laboratory Documentation

  • Record mg per tablet and manufacturer lot on each run.
  • Store orals in dry, controlled conditions.
  • Cross-reference drug class (SERM vs AI vs agonist) in your protocol registry.
  • Never use “PCT” language in human-facing materials — these are research reference compounds.

Summary

SERMs, aromatase inhibitors, and dopamine agonists are standard tools in HPG axis and oestrogen signalling research. New Zealand laboratories can procure Clomid, Arimidex, cabergoline, and related ancillaries from kiwibiolab.com alongside injectable oils and peptides.


Disclaimer: For laboratory and research use only. Not for human consumption. Not clinical treatment guidance.